Explore Our Comprehensive Life Sciences Industry Research Reports
P
2023
The global HIV drugs market was valued at $32.8 billion in 2022, and is projected to reach $51.1 billion by 2032, growing at a CAGR of 4.5% from 2023 to 2032.
Report Code : A01537 | Pages : 35 | Category : Life Sciences
P
2024
The global hiv diagnosis market was valued at $1.9 billion in 2022, and is projected to reach $2.7 billion by 2032, growing at a CAGR of 3.9% from 2023 to 2032.
Report Code : A02480 | Pages : 290 | Category : Life Sciences
A
2024
Report Overview
The report highlights numerous factors that influence the growth of the global Anti-viral therapeutics market such as market demand ...
Report Code : A128195 | Category : Life Sciences
A
2024
The global Hiv and aids testing market report covers market size, share, growth ...
Report Code : A135106 | Category : Life Sciences
U
2024
Human immunodeficiency virus (HIV) attacks the body’s immune system. If untreated, it causes acquired immunodeficiency syndrome (AIDS).
Report Code : A14032 | Category : Life Sciences
A
2024
The study on the Aids test kits market offers insights, information, and recommendation ...
Report Code : A140901 | Category : Life Sciences
A
2024
The report offers a thorough analysis of the global Hiv associated lipodystrophy syndrome treatment market with detailed study of various aspects such as market ...
Report Code : A154981 | Category : Life Sciences
P
2023
The U.S. Oral Antiviral Market is segmented into season type, rim size, vehicle type, and distribution channel. The U.S. Oral Antiviral Market growth is attributed to various driving factors and opportunities.
Report Code : A188179 | Pages : 85 | Category : Life Sciences
P
2023
The Distribution Channel has the highest CAGR over the analysis period. The section Top Winning Strategies from report provides insights about most frequently adopted strategies by key players in the market.
Report Code : A188180 | Pages : 76 | Category : Life Sciences
P
2023
The Mexico Oral Antiviral Market achieved significant revenue share in base year of analysis. The Mexico Oral Antiviral Market size is expected to account for a considerable growth rate between 2022 to 2031.
Report Code : A188181 | Pages : 86 | Category : Life Sciences
Register and Earn 500 Loyalty Points
An Email Verification Code has been sent to your email address!
Please check your inbox and, if you don't find it there, also look in your junk folder.